- INTRODUCTION TO NEUROCOGNITIVE DISORDERS (NCDS)
- DSM-5-TR AND ICD-11 DIAGNOSTIC FRAMEWORKS
- DISTINGUISHING MAJOR VS. MILD NCDS
- HISTORICAL PERSPECTIVES: FROM “SENILITY” TO MODERN DEMENTIA CONCEPTS
- NEUROCOGNITIVE DOMAINS: MEMORY, EXECUTIVE FUNCTION, ATTENTION
- COGNITIVE RESERVE AND BRAIN RESILIENCE
- NORMAL AGING VS. PATHOLOGICAL AGING
- EPIDEMIOLOGY AND GLOBAL BURDEN OF NCDS
- EARLY WARNING SIGNS AND SCREENING CONCEPTS
- ETHICS AND CAPACITY IN NEUROCOGNITIVE DISORDERS
- NEUROANATOMY OF MEMORY AND COGNITION
- SYNAPTIC PLASTICITY AND NEURODEGENERATION
- AMYLOID AND TAU PATHOLOGY IN ALZHEIMER’S DISEASE
- VASCULAR MECHANISMS OF COGNITIVE DECLINE
- ALPHA-SYNUCLEIN AND LEWY BODY DISEASE
- TDP-43 AND FRONTOTEMPORAL DEGENERATION
- HUNTINGTON’S GENE AND POLYGLUTAMINE EXPANSION
- ROLE OF NEUROINFLAMMATION AND MICROGLIA
- OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION
- GUT–BRAIN AXIS IN NEURODEGENERATIVE DISORDERS
- PATHOPHYSIOLOGY OF DELIRIUM: NEUROTRANSMITTER IMBALANCE
- DELIRIUM VS. DEMENTIA: KEY DISTINCTIONS
- PREDISPOSING AND PRECIPITATING FACTORS
- HOSPITAL-ASSOCIATED DELIRIUM IN OLDER ADULTS
- SUBSTANCE- AND MEDICATION-INDUCED DELIRIUM
- NEUROIMAGING AND BIOMARKERS OF DELIRIUM
- ACUTE VS. PERSISTENT DELIRIUM
- PREVENTION AND RISK REDUCTION CONCEPTS
- CULTURAL AND HISTORICAL PERSPECTIVES ON DELIRIUM
- LONG-TERM COGNITIVE SEQUELAE OF DELIRIUM
- GENETICS OF ALZHEIMER’S: APOE, APP, PSEN MUTATIONS
- AMYLOID CASCADE HYPOTHESIS AND ALTERNATIVES
- TAU PATHOLOGY AND NEUROFIBRILLARY TANGLES
- EARLY-ONSET VS. LATE-ONSET ALZHEIMER’S
- MILD COGNITIVE IMPAIRMENT AS A PRECURSOR TO ALZHEIMER’S
- NEUROIMAGING IN ALZHEIMER’S DISEASE
- BIOMARKERS: CSF, AMYLOID PET, PLASMA ASSAYS
- CHOLINERGIC HYPOTHESIS OF ALZHEIMER’S
- CURRENT AND EMERGING PHARMACOLOGIC THEORIES (E.G., ANTI-AMYLOID ANTIBODIES)
- PUBLIC HEALTH STRATEGIES FOR ALZHEIMER’S PREVENTION
- MULTI-INFARCT DEMENTIA: CONCEPTS AND PATHWAYS
- SMALL VESSEL DISEASE AND WHITE MATTER LESIONS
- STRATEGIC INFARCT DEMENTIA
- CORTICAL VS. SUBCORTICAL VASCULAR NCD
- NEUROIMAGING OF VASCULAR CONTRIBUTIONS TO DEMENTIA
- INTERACTION OF ALZHEIMER’S AND VASCULAR PATHOLOGY
- CARDIOVASCULAR RISK FACTORS AND BRAIN HEALTH
- CEREBRAL AMYLOID ANGIOPATHY
- STROKE REHABILITATION AND COGNITIVE RECOVERY (THEORY ONLY)
- GLOBAL BURDEN OF VASCULAR NCD
- DEMENTIA WITH LEWY BODIES: CORE FEATURES
- VISUAL HALLUCINATIONS AND REM SLEEP BEHAVIOR DISORDER
- PARKINSON’S DISEASE DEMENTIA: CLINICAL COURSE
- ALPHA-SYNUCLEIN PATHOLOGY AND SPREAD
- NEUROCHEMICAL CHANGES IN LEWY BODY DISEASE
- DISTINGUISHING LEWY BODY DEMENTIA FROM ALZHEIMER’S
- AUTONOMIC DYSFUNCTION AND COGNITION
- MOTOR-COGNITIVE INTERACTIONS IN PARKINSON’S
- GENETIC AND ENVIRONMENTAL RISK FACTORS
- THEORIES OF REM SLEEP BEHAVIOR DISORDER AS PRODROME
- BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA
- SEMANTIC VARIANT PRIMARY PROGRESSIVE APHASIA
- NONFLUENT/AGRAMMATIC VARIANT PPA
- GENETICS OF FTLD: MAPT, GRN, C9ORF72
- TDP-43 VS. TAU PATHOLOGY
- SOCIAL COGNITION DEFICITS IN FTLD
- PSYCHIATRIC MISDIAGNOSIS IN FTLD
- LANGUAGE AND EXECUTIVE FUNCTION CHANGES
- NEUROIMAGING PATTERNS IN FTLD
- CULTURAL AND FAMILIAL ASPECTS OF FTLD
- HUNTINGTON’S DISEASE: GENETICS AND NEURODEGENERATION
- PRION DISEASES (E.G., CREUTZFELDT–JAKOB DISEASE)
- HIV-ASSOCIATED NEUROCOGNITIVE DISORDER
- TRAUMATIC BRAIN INJURY AND CHRONIC TRAUMATIC ENCEPHALOPATHY
- NORMAL PRESSURE HYDROCEPHALUS AND COGNITIVE SYMPTOMS
- POST-STROKE COGNITIVE IMPAIRMENT
- MULTIPLE SCLEROSIS AND COGNITIVE DYSFUNCTION
- EPILEPSY-RELATED COGNITIVE DECLINE
- SYPHILIS AND OTHER INFECTIOUS CAUSES
- ENDOCRINE AND METABOLIC CAUSES OF NCD
- DEPRESSION AND PSEUDODEMENTIA
- ANXIETY AND NEUROCOGNITIVE DECLINE
- SUBSTANCE USE AND NEUROTOXICITY
- SLEEP DISORDERS AND COGNITIVE IMPAIRMENT
- CARDIOMETABOLIC FACTORS AND COGNITIVE HEALTH
- FRAILTY AND MULTIMORBIDITY
- SOCIAL ISOLATION AND COGNITIVE DECLINE
- ROLE OF EDUCATION AND COGNITIVE RESERVE
- PHYSICAL ACTIVITY AND NEUROPROTECTION
- NUTRITION AND COGNITIVE AGING
- PHARMACOLOGIC THEORIES FOR SYMPTOMATIC MANAGEMENT (CHOLINESTERASE INHIBITORS, MEMANTINE)
- EMERGING DISEASE-MODIFYING APPROACHES (ANTI-AMYLOID, ANTI-TAU)
- COGNITIVE REHABILITATION AND ENVIRONMENTAL DESIGN
- LIFESTYLE INTERVENTIONS: DIET, EXERCISE, SOCIAL ENGAGEMENT
- TECHNOLOGY AND AI IN COGNITIVE ASSESSMENT
- BIG DATA AND PREDICTIVE ANALYTICS IN DEMENTIA
- PUBLIC HEALTH STRATEGIES FOR DEMENTIA PREVENTION
- ETHICS OF GENETIC TESTING AND EARLY DETECTION
- HEALTH ECONOMICS AND GLOBAL AGING POLICY
- FUTURE DIRECTIONS: PRECISION GERIATRIC PSYCHIATRY